Cargando…

Immune Cell Infiltration Landscape of Ovarian Cancer to Identify Prognosis and Immunotherapy-Related Genes to Aid Immunotherapy

Ovarian cancer (OC) is the second leading cause of death in gynecological cancer. Multiple study have shown that the efficacy of tumor immunotherapy is related to tumor immune cell infiltration (ICI). However, so far, the Immune infiltration landscape of tumor microenvironment (TME) in OC has not be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiushen, Liang, Weizheng, Zhao, Huanyi, Jin, Zheng, Shi, Guoqi, Xie, Wanhua, Wang, Hao, Wu, Xueqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595115/ https://www.ncbi.nlm.nih.gov/pubmed/34805159 http://dx.doi.org/10.3389/fcell.2021.749157

Ejemplares similares

Characterization of the Different Subtypes of Immune Cell Infiltration to Aid Immunotherapy
por: Li, Zhenqing, et al.
Publicado: (2022)

Landscape of Prognostic m6A RNA Methylation Regulators in Hepatocellular Carcinoma to Aid Immunotherapy
por: Xu, Qianhui, et al.
Publicado: (2021)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma
por: Zhang, Li, et al.
Publicado: (2022)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

Association of Angiogenesis Gene Expression With Cancer Prognosis and Immunotherapy Efficacy
por: Li, Xin-yu, et al.
Publicado: (2022)

Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma
por: Shi, Junfeng, et al.
Publicado: (2022)

Transcriptomic and Metabolomic Profiling in Helicobacter pylori–Induced Gastric Cancer Identified Prognosis- and Immunotherapy-Relevant Gene Signatures
por: Liu, Duanrui, et al.
Publicado: (2021)

The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
por: Xie, Rongrong, et al.
Publicado: (2022)

Prognosis and Immunotherapy Significances of a Cancer-Associated Fibroblasts-Related Gene Signature in Gliomas
por: Chen, Zhimin, et al.
Publicado: (2021)

Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy
por: Canning, Madison, et al.
Publicado: (2019)

Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies
por: Filipovic, Aleksandra, et al.
Publicado: (2020)

Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy?
por: He, Yingying, et al.
Publicado: (2021)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021)

CD93 Correlates With Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis
por: Zhang, Zerui, et al.
Publicado: (2022)

Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Luo, Cong, et al.
Publicado: (2021)

Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy
por: Zhong, Weimin, et al.
Publicado: (2021)

Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
por: Jiang, Yupeng, et al.
Publicado: (2022)

Ubiquitin Modification Patterns of Clear Cell Renal Cell Carcinoma and the Ubiquitin Score to Aid Immunotherapy and Targeted Therapy
por: Zhou, Peng, et al.
Publicado: (2021)

Lipid metabolism and tumor immunotherapy
por: Wang, Yue, et al.
Publicado: (2023)

Pan-Cancer Study on Protein Kinase C Family as a Potential Biomarker for the Tumors Immune Landscape and the Response to Immunotherapy
por: Abdelatty, Alaa, et al.
Publicado: (2022)

A Novel Signature of Lipid Metabolism-Related Gene Predicts Prognosis and Response to Immunotherapy in Lung Adenocarcinoma
por: Zhang, Kai, et al.
Publicado: (2022)

Prognosis-related genes participate in immunotherapy of renal clear cell carcinoma possibly by targeting dendritic cells
por: Fang, Guodong, et al.
Publicado: (2022)

Identification of CHMP7 as a promising immunobiomarker for immunotherapy and chemotherapy and impact on prognosis of colorectal cancer patients
por: Guo, Yu, et al.
Publicado: (2023)

To Identify Adenomatous Polyposis Coli Gene Mutation as a Predictive Marker of Endometrial Cancer Immunotherapy
por: Song, Yunfeng, et al.
Publicado: (2022)

Progress in Neoantigen Targeted Cancer Immunotherapies
por: Han, Xue-Jiao, et al.
Publicado: (2020)

Targeting alternative splicing in cancer immunotherapy
por: Han, Nan, et al.
Publicado: (2023)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell Carcinoma
por: Gao, Ze, et al.
Publicado: (2021)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano-del Valle, Alfonso, et al.
Publicado: (2019)

Peritoneal resident macrophages in tumor metastasis and immunotherapy
por: Zhang, Yu, et al.
Publicado: (2022)

Towards Immunotherapy-Induced Normalization of the Tumor Microenvironment
por: Melo, Vinicio, et al.
Publicado: (2022)

The application of mechanobiotechnology for immuno-engineering and cancer immunotherapy
por: Yoon, Chi Woo, et al.
Publicado: (2022)

Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications
por: Salah, Ahmed, et al.
Publicado: (2021)

CMTM Family Genes Affect Prognosis and Modulate Immunocytes Infiltration in Grade II/III Glioma Patients by Influencing the Tumor Immune Landscape and Activating Associated Immunosuppressing Pathways
por: Wang, Zeyu, et al.
Publicado: (2022)

Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma
por: Ren, Ziyuan, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

Pyroptosis-Related lncRNAs for Predicting the Prognosis and Identifying Immune Microenvironment Infiltration in Breast Cancer Lung Metastasis
por: Liu, Li, et al.
Publicado: (2022)

Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma
por: Zhao, Han, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_amrhb3pftnlkef0ff1ml7ofj0b